Professor Dr. Rene Bernards - Gilde Healthcare

team
Venture&Growth

All team members
Professor Dr. Rene Bernards
Operational Partner
United States of America

Professor Dr. Rene Bernards

Operational Partner

Professor Dr René Bernards brings extensive experience in oncology as a researcher and a serial entrepreneur. He is a Professor at the Netherlands Cancer Institute (NKI). He performed his post-doctoral research at the Massachusetts Institute of Technology in Robert Weinberg’s group at the Whitehead Institute. He joined Harvard Medical School as an assistant professor in 1988 to study function of oncogenes and tumor suppressor genes He received his PhD in 1984 from the University of Leiden. In 1994 he was appointed part time professor of molecular carcinogenesis at Utrecht University, The Netherlands.

His laboratory focuses on the development of new tools to perform genome-wide genetic screens to identify novel genes that act in cancer relevant pathways.His research has produced 14 clinical trials (including 2 global Phase 3 trials).

He has co-founded Agendia in 2003, Prolifix in 1993 (currently TopoTarget) and Qameleon.

At Gilde he actively contributes his experience in drug target discovery, preclinical and clinical development and precision medicine in the evaluation of investment opportunities in oncology, company building and portfolio management.

Karthik Bolisetty

Senior Associate Healthtech
Venture&Growth
Karthik Bolisetty joined Gilde Healthcare in 2023 in the Boston office and focuses on Healthtech. Prior to joining Gilde, Karthik was on the investment team at Northpond Ventures, where he focused primarily on investments in...

Rich Wilmot

Partner HealthTech
Venture&Growth
Rich Wilmot joined Gilde in 2023 as a Partner in the Boston office. Prior to joining, Rich was the Global Head of Ventures at Philips, where he was responsible for creating, launching and running the...

Pieter van der Meer

Managing Partner
Pieter van der Meer is founder and managing partner of Gilde Healthcare. Pieter joined Gilde in 1998 following a consultant position with KPMG Management Consulting. He is co-responsible for general management, the investment committees and...